Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rohto Dry-Aid vs Systane Ultra in Dry Eye
NCT03183089Phase 4Completed
- Sponsor
- Mentholatum
- Start
- Dec 2015
- Primary completion
- Jan 2016
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol 400 + propylene glycol in dry eye syndrome (DED), sponsored by Mentholatum. Started Dec 2015; status: completed.
02
Drugs
polyethylene glycol 400 + propylene glycol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03183089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183089.